HIKAL
Double Top Buy triggered today above 707.72 daily close on 3% Box Size chart.
Hybrid CDMO! https://t.co/SHqEUZG0WP
HIKAL
— Saket Reddy (@saketreddy) July 20, 2021
Double Top Buy triggered above 554.72 daily close on 1% Box Size chart. pic.twitter.com/70Ajvt8dtZ
More from Saket Reddy
Double Top Buy above 2233.36 daily close on 1% Box size chart. https://t.co/Grtz9Pi3vU
MINDTREE
— Saket Reddy (@saketreddy) December 22, 2020
The company is an international information technology consulting and implementation organisation that delivers business solutions through global software development.
DTB above 1619.22 daily close on 3% box size chart, DTB active on 1% chart. https://t.co/dhQmouQ9Wt pic.twitter.com/g8Rgz7fA0A
The industry further has potential to capture incremental opportunity of 4500-5000Cr low-end plywood market. https://t.co/Cre3xVUNqu
GREENPANEL would grow earnings at 15-20% CAGR over the next 3-5 years with ROCE & Margin expansion once they commision the de-bottlenecked capacity in FY22 and the brownfield AP CAPEX in FY23/FY24.
— Saket Reddy (@saketreddy) October 14, 2021
Huge runway for growth, industry structure (both MDF & RE) turned for the good! https://t.co/jFTZCwhNMS
GREENPANEL had 1,400 dealers (retail business) as of FY21 and added 250 dealers in 6MFY22. Target to
increase this to 2,200 by FY23.
More from Hikal
🧪 Lowered interest rates
🧪 Pharma: Growth in generics as well as CDMO
🧪 Crop Protection: Scaleup of a fungicide for a Japanese CDMO client
🧪 Healthy pipeline of new products: Supported by new capacities; Investing in Animal Health & Biocides verticals https://t.co/D70j9oriCa
Hikal: Strong
— JST Investments (@JstInvestments) August 5, 2021
\U0001f9ea Rev up 27% YoY
\U0001f9ea 22% EBITDA margin
\U0001f9ea Pat of 50crs
\U0001f9ea Growth across both pharmaceuticals & crop protection.#Q1withJST #Pharma pic.twitter.com/8lFo68KzPe